Cromwell Holdings’s GSK GSK Stock Holding History

Cromwell Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.1K	Sell	923 -536	-37%	-$28.3K	0.02%	484
2026 Q1	$81K	Buy	1,459 +536	+58%	+$29K	0.05%	373
2025 Q4	$45.7K	Hold	923	–	–	0.02%	474
2025 Q3	$40.2K	Hold	923	–	–	0.02%	514
2025 Q2	$35.8K	Hold	923	–	–	0.02%	510
2025 Q1	$35.8K	Sell	923 -1,982	-68%	-$72.6K	0.02%	515
2024 Q4	$98.2K	Sell	2,905 -1,358	-32%	-$48.9K	0.06%	289
2024 Q3	$176K	Hold	4,263	–	–	0.11%	177
2024 Q2	$166K	Buy	+4,263	New	+$179K	0.1%	176

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cromwell Holdings's GSK Position: Q2 2026 in Review

Cromwell Holdings reduced its GSK (GSK) stake by 37% in Q2 2026, selling an estimated $28.3K and leaving 923 shares worth $49.1K. The position accounts for 0.02% of the portfolio, ranked #484.

Cromwell Holdings first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $176K in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Cromwell Holdings held 923 shares of GSK worth $49.1K as of Q2 2026.
Cromwell Holdings sold 536 GSK shares in Q2 2026, an estimated $28.3K.
GSK made up 0.02% of Cromwell Holdings's portfolio in Q2 2026, its #484 holding.
Cromwell Holdings first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's GSK position peaked at $176K in Q3 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.